非变应性鼻炎

Nassef M, Shapiro G, Casale TB. Identifying and managing rhinitis and its subtypes: allergic and non-allergic components - a consensus report and materials from the Respiratory Allergic Disease Foundation. Curr Med Res Opin. 2006 Dec;22(12):2541-8.

• 摘要

Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998 Nov;81(5 Pt 2):478-518.

• 摘要

Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol. 2006;96:526-532.

• 摘要

Bernstein JA, Levin LS, Al-Shuik E, et al. Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens. Ann Allergy Asthma Immunol. 2012;109:173-178.

• 摘要

1.  Kaliner MA, Baraniuk JN, Benninger M, et al. Consensus definition of nonallergic rhinopathy, previously referred to as vasomotor rhinitis, nonallergic rhinitis, and/or idiopathic rhinitis. World Allergy Organ J. 2009 Jun 15;2(6):119-20.

• 全文
• 摘要

2.  Nassef M, Shapiro G, Casale TB. Identifying and managing rhinitis and its subtypes: allergic and non-allergic components - a consensus report and materials from the Respiratory Allergic Disease Foundation. Curr Med Res Opin. 2006 Dec;22(12):2541-8.

• 摘要

3.  Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998 Nov;81(5 Pt 2):478-518.

• 摘要

4.  Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (rev ed 2017). Clin Exp Allergy. 2017 Jul;47(7):856-89.

• 全文
• 摘要

5.  Settipane RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc. 2001;22:185-189.

• 摘要

6.  Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001;86:494-508.

• 摘要

7.  Baraniuk JN, Kaliner MA. Neuropeptides and nasal secretion. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 2):620-7.

• 摘要

8.  Garay R. Mechanisms of vasomotor rhinitis. Allergy. 2004;59 Suppl 76:4-9; discussion 9-10.

• 摘要

9.  Bernstein JA, Singh U. Neural abnormalities in nonallergic rhinitis. Curr Allergy Asthma Rep. 2015 Apr;15(4):18.

• 摘要

10.  Bernstein JA, Hastings L, Boespflug EL, et al. Alteration of brain activation patterns in nonallergic rhinitis patients using functional magnetic resonance imaging before and after treatment with intranasal azelastine. Ann Allergy Asthma Immunol. 2011 Jun;106(6):527-32.

• 摘要

11.  Bernstein JA, Davis BP, Picard JK, et al. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol. 2011 Aug;107(2):171-8.

• 摘要

12.  Singh U, Bernstein JA. Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis. Prog Drug Res. 2014;68:147-70.

• 摘要

13.  Singh U, Bernstein JA, Haar L, et al. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis. Am J Rhinol Allergy. 2014 May-Jun;28(3):215-24.

• 摘要

14.  Powe DG, Huskisson RS, Carney AS, et al. Mucosal T-cell phenotypes in persistent atopic and nonatopic rhinitis show an association with mast cells. Allergy. 2004 Feb;59(2):204-12.

• 摘要

15.  Terada N, Konno A, Fukuda S, et al. Interleukin-5 upregulates intercellular adhesion molecule-1 gene expression in the nasal mucosa in nasal allergy but not in nonallergic rhinitis. Int Arch Allergy Immunol. 1995 Feb;106(2):139-45.

• 摘要

16.  Demoly P, Sahla M, Campbell AM, et al. ICAM-1 expression in upper respiratory mucosa is differentially related to eosinophil and neutrophil inflammation according to the allergic status. Clin Exp Allergy. 1998 Jun;28(6):731-8.

• 摘要

17.  Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol. 2006;96:526-532.

• 摘要

18.  Bernstein JA, Levin LS, Al-Shuik E, et al. Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens. Ann Allergy Asthma Immunol. 2012;109:173-178.

• 摘要

19.  Meltzer EO, Orgel HA, Rogenes PR, et al. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate. J Allergy Clin Immunol. 1994 Oct;94(4):708-15.

• 摘要

20.  Bernstein JA, Salapatek AM, Lee JS, et al. Provocation of nonallergic rhinitis subjects in response to simulated weather conditions using an environmental exposure chamber model. Allergy Asthma Proc. 2012 Jul-Aug;33(4):333-40.

• 摘要

21.  Meltzer EO, Nathan RA, Derebery J, et al. Physician perceptions of the treatment and management of allergic and nonallergic rhinitis. Allergy Asthma Proc. 2009 Jan-Feb;30(1):75-83.

• 摘要

22.  Staevska M, Baraniuk JN. Persistent nonallergic rhinosinusitis. Curr Allergy Asthma Rep. 2005 May;5(3):233-42.

• 摘要

23.  Campo P, Rondón C, Gould HJ, et al. Local IgE in non-allergic rhinitis. Clin Exp Allergy. 2015 May;45(5):872-81.

• 摘要

24.  Sur DKC, Plesa ML. Chronic nonallergic rhinitis. Am Fam Physician. 2018 Aug 1;98(3):171-76.

• 摘要

25.  Spector SL. The placebo effect is nothing to sneeze at. J Allergy Clin Immunol. 1992 Dec;90(6 Pt 2):1042-3.

• 摘要

26.  LaForce CF, Corren J, Wheeler WJ, et al. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Ann Allergy Asthma Immunol. 2004 Aug;93(2):154-9.

• 摘要

27.  Berger WE, White MV. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann Allergy Asthma Immunol. 2003 Aug;91(2):205-11.

• 摘要

28.  Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001 Jan;86(1):28-35.

• 摘要

29.  Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy. 2004;59 Suppl 76:16-22; discussion 22-3.

• 摘要

30.  Bernstein JA. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. Curr Med Res Opin. 2007 Oct;23(10):2441-52.

• 摘要

31.  Kaliner MA. A novel and effective approach to treating rhinitis with nasal antihistamines. Ann Allergy Asthma Immunol. 2007 Nov;99(5):383-90; quiz 391-2, 418.

• 摘要

32.  Dockhorn R, Aronson D, Bronsky E, et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol. 1999 Apr;82(4):349-59.

• 摘要

33.  Scadding GK, Lund VJ, Jacques LA, et al. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy. 1995 Aug;25(8):737-43.

• 摘要

34.  Swierczynska M, Strek P, Skladzien J, et al. Nonallergic rhinitis with eosinophilia syndrome: state of knowledge. Otolaryngol Pol. 2003;57(1):81-4.

• 摘要

35.  Meltzer EO. The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids. Allergy. 1997;52(36 Suppl):33-40.

• 摘要

36.  Balle VH, Pedersen U, Engby B. Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray. Rhinology. 1980 Sep;18(3):135-42.

• 摘要

37.  Lundblad L, Sipilä P, Farstad T, et al. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2001;121:505-509.

• 摘要

38.  Georgitis JW, Banov C, Boggs PB, et al. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Clin Exp Allergy. 1994 Nov;24(11):1049-55.

• 摘要

39.  Bronsky EA, Druce H, Findlay SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol. 1995 May;95(5 pt 2):1117-22.

• 摘要

40.  Hellings PW, Klimek L, Cingi C, et al. Non-allergic rhinitis: Position Paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017 Jun 2;72(11):1657-65.

• 全文
• 摘要

41.  Vaidyanathan S, Williamson P, Clearie K, et al. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. Am J Respir Crit Care Med. 2010 Jul 1;182(1):19-24.

• 全文
• 摘要

42.  Baroody FM, Brown D, Gavanescu L, et al. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr;127(4):927-34.

• 全文
• 摘要

43.  Sandhu AS, Temple RH, Timms MS. Partial laser turbinectomy: two year outcomes in patients with allergic and non-allergic rhinitis. Rhinology. 2004 Jun;42(2):81-4.

• 摘要

44.  Mladina R, Risavi R, Subaric M. CO2 laser anterior turbinectomy in the treatment of non-allergic vasomotor rhinopathia. A prospective study upon 78 patients. Rhinology. 1991 Dec;29(4):267-71.

• 摘要

45.  Gevorgyan A, Segboer C, Gorissen R, et al. Capsaicin for non-allergic rhinitis. Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010591.

• 全文
• 摘要

46.  Van Gerven L, Alpizar YA, Wouters MM, et al. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. J Allergy Clin Immunol. 2014 May;133(5):1332-9, 1339.

• 摘要

47.  Holland C, van Drunen C, Denyer J, et al. Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist. Br J Clin Pharmacol. 2014 May;77(5):777-88.

• 摘要

48.  Murdoch RD, Bareille P, Denyer J, et al. TRPV1 inhibition does not prevent cold dry air-elicited symptoms in non-allergic rhinitis. Int J Clin Pharmacol Ther. 2014 Apr;52(4):267-76.

• 摘要

49.  Lieberman P, Meltzer EO, LaForce CF, et al. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis. Allergy Asthma Proc. 2011 Mar-Apr;32(2):151-8.

• 全文
• 摘要

50.  Ozcan C, Ismi O. Botulinum toxin for rhinitis. Curr Allergy Asthma Rep. 2016 Aug;16(8):58.

• 摘要

51.  Juto JE, Axelsson M. Kinetic oscillation stimulation as treatment of non-allergic rhinitis: an RCT study. Acta Otolaryngol. 2014 May;134(5):506-12.

• 全文
• 摘要

52.  Deenadayal DS, Kumar MN, Sudhakshin P, et al. Radiofrequency reduction of inferior turbinates in allergic and non allergic rhinitis. Indian J Otolaryngol Head Neck Surg. 2014 Jan;66(Suppl 1):231-6.

• 摘要

53.  Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache. Arch Intern Med. 2004 Sep 13;164(16):1769-72.

• 摘要

54.  Bernstein JA, Fox RW, Martin VT, et al. Headache and facial pain: differential diagnosis and treatment. J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):242-51.

• 摘要

55.  Martin VT, Fanning KM, Serrano D, et al. Chronic rhinitis and its association with headache frequency and disability in persons with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Cephalalgia. 2014 Apr;34(5):336-48.

• 摘要